Christopher Robinson
Maternal & Fetal Medicine · Mount Pleasant, SCNPI 1750353355
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $110,248 of the $121,149 with a category attached, or 91.0%. It is spread thinly across 22 manufacturers, the largest accounting for just 18.4%. Among maternal & fetal medicine clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $1408.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AMAG Pharmaceuticals, Inc.$22K
- Seqirus USA Inc$15K
- UCB, Inc.$12K
- Medicines360$12K
- AbbVie$9K
- Teva Pharmaceuticals USA, Inc.$8K
- plus $43K from 16 others
Across 9 payments — averaging $3362.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$14K
- Teva Pharmaceuticals USA, Inc.$10K
- Harmony Biosciences LLC$4K
- Sumitomo Pharma America, Inc.$2K
What the payments were for
- Consulting fees$110,24891%
- Speaking & faculty fees$6,3555%
- Travel & lodging$2,0252%
- Food & beverage$5200%
- Gifts$2,0002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AMAG Pharmaceuticals, Inc. | 7 | $22,343 |
| Seqirus USA Inc | 8 | $14,906 |
| UCB, Inc. | 17 | $12,123 |
| Medicines360 | 3 | $11,570 |
| AbbVie(2 entities) | 7 | $9,478 |
| Teva Pharmaceuticals USA, Inc. | 3 | $7,734 |
| Pfizer | 2 | $7,650 |
| Grifols USA, LLC | 9 | $7,314 |
| Janssen Scientific Affairs, LLC | 7 | $6,545 |
| Novo Nordisk AS | 6 | $4,975 |
| Axsome Therapeutics, Inc. | 1 | $4,750 |
| Janssen Research & Development, LLC | 3 | $3,750 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $2,750 |
| Samsung HME America, Inc. | 1 | $2,000 |
| Lupin Inc. | 2 | $1,134 |
| Exeltis, USA Inc. | 2 | $736 |
| UCB SA | 1 | $450 |
| Alnylam Pharmaceuticals Inc. | 1 | $385 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $298 |
| Medicem Inc. | 2 | $220 |
| GE HealthCare | 1 | $23 |
| Organon | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LILETTA$11,570
- NURTEC ODT$10,400
- Skyrizi$8,463
- Cimzia$8,451
- AJOVY$7,734
- FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)$7,731
- Thrombate III$7,265
- SUNOSI$4,750
- AFLURIA QUADRIVALENT$2,100
- SOLOSEC$1,060
- Slynd$736
- DILAPAN-S$200
- Nuvessa$168
How this compares
$121,149 in reported general payments places this provider in the 95th percentile of 34 maternal & fetal medicine providers in South Carolina.
See all maternal & fetal medicine providers in South Carolina →
Other maternal & fetal medicine in Mount Pleasant
- Alison DillonMount Pleasant$109
- Anthony GreggColumbia$50K
- Eugene ChangCharleston$5K
- Alexander SmytheColumbia$700
- Erin DickertGreenville$662
- Phillip GreigGreenville$305
- Paul BrowneWest Columbia$284
- Jill BolandGreenville$261
- Richard AdamsColumbia$184
- Barbara HeadCharleston$165
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.